<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-695X</journal-id>
<journal-title><![CDATA[Revista Clínica de Medicina de Familia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Clin Med Fam]]></abbrev-journal-title>
<issn>1699-695X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Medicina de Familia y Comunitaria]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-695X2020000200005</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Patrones de susceptibilidad antimicrobiana &#8220;in vitro&#8221; de bacterias Gram negatives asilades de infección de vías urinarias en pacientes ambulatorios de una clínica del sur de la Ciudad de México]]></article-title>
<article-title xml:lang="en"><![CDATA[Patterns of in vitro antimicrobial susceptibility of Gram-negative bacteria isolated from urinary tract infections in outpatients of a clinic in southern Ciudad de México]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morales-Espinosa]]></surname>
<given-names><![CDATA[Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Contreras Hernández]]></surname>
<given-names><![CDATA[Iván Filiberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Duran Ángeles]]></surname>
<given-names><![CDATA[Addy Bensibet]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olivares Luna]]></surname>
<given-names><![CDATA[Ana María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valencia Gómez]]></surname>
<given-names><![CDATA[Claudia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García de la Cruz]]></surname>
<given-names><![CDATA[Yocelin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Pedraza Aviles]]></surname>
<given-names><![CDATA[Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Medicina Laboratorio de Genómica Bacteriana. Departamento de Microbiología y Parasitología]]></institution>
<addr-line><![CDATA[Cd de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado Clínica de Medicina Familiar (CMF). Ignacio Chávez ]]></institution>
<addr-line><![CDATA[Cd de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>13</volume>
<numero>2</numero>
<fpage>131</fpage>
<lpage>138</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-695X2020000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-695X2020000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-695X2020000200005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo: Determinar los patrones de susceptibilidad antimicrobiana de bacterias Gram negativas aisladas de cultivos de orina de pacientes ambulatorios, y asociarlos con variables como edad, sexo, infección urinaria previa y presencia de diabetes mellitus tipo 2.  Material y métodos: Estudio descriptivo observacional y trasversal, con cepas aisladas de 278 pacientes con infección urinaria baja, que acudieron a consulta externa a la CMF Dr. Ignacio Chávez del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, del sur de la Ciudad de México, entre los meses de marzo de 2018 a febrero de 2019. Se utilizó el sistema Phoenix 100 de Becton Dickinson, tanto para identificación de cepas, como para determinación de susceptibilidad antimicrobiana. Se probaron 16 antimicrobianos. Se utilizó estadística descriptiva para determinar proporción de resistencias. Programa estadístico SPSS versión 22.  Resultados: Se incluyeron 278 cepas: 231 Escherichia coli, 24 Klebsiella spp; 8 Enterobacter spp, 7 Proteus spp, 7 Citrobacter spp, 1 Serratia spp. La mayor resistencia fue para: ampicilina con 74,1 %, y la mayor sensibilidad para amikacina con 100 %. Del total de cepas, 140 (50,4 %) fueron Multi-Drogo-Resistentes, no hubo cepas Pan-Drogo-Resistentes. Al asociar las variables de estudio con la resistencia a cada antimicrobiano, sólo se obtuvo significancia estadística entre las cefalosporinas cefaxolina y cefoxitin, y el imipenem con el sexo de los pacientes, con mayor porcentaje en los hombres.  Conclusiones: Se obtuvo una alta resistencia en prácticamente todos los grupos de antimicrobianos, lo que hace necesario estar al tanto de los patrones de susceptibilidad en cada zona o país.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objectives: To determine patterns of antimicrobial susceptibility of Gram-negative bacteria isolated from urine cultures of outpatients, and to associate them with variables such as age, sex, previous urinary infection, and presence of type-2 diabetes mellitus.  Material and methods: Descriptive, observational, cross-sectional study, with strains isolated from 278 patients with low urinary infection, who had outpatient consultation in CMF Dr. Ignacio Chávez of the Instituto de Seguridad y Servicios Sociales de los Trabajadoresdel Estado, in southern Ciudad de México, between March 2018 and February 2019. The Becton-Dickinson Phoenix 100 system was used both for identifying strains, and for determining antimicrobial susceptibility. 16 antimicrobial agents were tested. Descriptive statistics was used for determining resistance proportion. Statistical programme SPSS version 22.  Results: 278 strains were included: 231 Escherichia coli, 24 Klebsiella spp., 8 Enterobacter spp., 7 Proteus spp., 7 Citrobacter spp., 1 Serratia spp. The greatest resistance was for: ampicillin with 74.1% and the greatest sensitivity was for amikacin with 100%. Of all strains, 140 (50.4%) were multidrug resistant, and none was pandrug resistant. When the study variables were associated with resistance to each antimicrobial, there was statistical significance only between cephalosporins cefazolin and cefoxitin, as well as imipenem with patient sex, with higher percentage in men.  Conclusions: High resistance was obtained in virtually all the groups of antimicrobials. This makes it necessary to be aware of susceptibility patterns in each area or country.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Infección de vías urinarias]]></kwd>
<kwd lng="es"><![CDATA[Pacientes ambulatorios]]></kwd>
<kwd lng="es"><![CDATA[Resistencia antimicrobiana]]></kwd>
<kwd lng="es"><![CDATA[Bacterias Gram negativas]]></kwd>
<kwd lng="es"><![CDATA[Escherichia coli]]></kwd>
<kwd lng="en"><![CDATA[Urinary tract infections]]></kwd>
<kwd lng="en"><![CDATA[Outpatients]]></kwd>
<kwd lng="en"><![CDATA[Antimicrobial drug resistance]]></kwd>
<kwd lng="en"><![CDATA[Gram-negative bacteria]]></kwd>
<kwd lng="en"><![CDATA[Escherichia coli]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guevara]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Merentes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Papaptzikos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rivero]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patrones de susceptibilidad antimicrobiana de bacterias Gram negativas aisladas de infecciones del tracto urinario en Venezuela: resultados del estudio SMART 2009-2012]]></article-title>
<source><![CDATA[Rev chil infectol]]></source>
<year>2015</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>639-48</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scholes]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hooton]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Stapleton]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Stamm]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for recurrenturinary tract infection in young women]]></article-title>
<source><![CDATA[J Infect Dis]]></source>
<year>2000</year>
<volume>182</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1177-82</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hooton]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Naber]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wullt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Colgan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[l]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2011</year>
<volume>52</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>e103-20</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hawser]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surveillance programmes and Antibiotic Resistance: Worldwide and Regional monitoring of antibiotic resistance trends]]></article-title>
<source><![CDATA[Handb Exp Pharmacol]]></source>
<year>2012</year>
<volume>211</volume>
<numero>211</numero>
<issue>211</issue>
<page-range>31-43</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galvan]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Agapito]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lagos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tamariz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización fenotípica y molecular de Escherichia coli productoras de &#946;-lactamasas de espectro extendido en pacientes ambulatorios de Lima, Perú]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2016</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[The evolving threat of antimicrobial resistance: options for action]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Magiorakos]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Srinivassan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carey]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Carmeli]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Falagas]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Giske]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance]]></article-title>
<source><![CDATA[Clin Microbiol Infect]]></source>
<year>2012</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>266-81</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mora-Hernández]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Padrón-Arredondo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resistencia bacteriana en urocultivos de un hospital de Quintana Roo durante un periodo de ocho meses]]></article-title>
<source><![CDATA[Rev Sal Quintana Roo]]></source>
<year>2017</year>
<volume>10</volume>
<numero>36</numero>
<issue>36</issue>
<page-range>18-24</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ny]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Edquist]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dumpis]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Gröndahl-Yli-Hannuksela]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hermes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kling]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibiotic resistance of Escherichia coli from outpatient urinary tract infection in women in six European countries including Russia]]></article-title>
<source><![CDATA[J Glob Antimicrob Resist]]></source>
<year>2019</year>
<volume>17</volume>
<page-range>25-34</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Betrán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cortés]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de la resistencia antibiótica de Escherichia coli en infecciones urinarias adquiridas en la comunidad del sector sanitario de Barbastro. Huelva.]]></article-title>
<source><![CDATA[Rev Esp Quimioter]]></source>
<year>2015</year>
<volume>28</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>263-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<source><![CDATA[Diagnóstico y tratamiento de la infección aguda, no complicada del tracto urinario de la mujer]]></source>
<year>2009</year>
<publisher-name><![CDATA[Secretaria de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mayorga Marín]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Perfil de resistencia y sensibilidad antimicrobiana en bacterias aisladas en urocultivos de usuarios que acuden al laboratorio de campus Médico UNAN-LEÓN. 2013-2014]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Managua, Nicaragua ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional Autónoma de Nicaragua]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Tello]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gimbernat]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Redondo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arana]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Cacho]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Angulo]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Betalactamasas de espectro extendido en las infecciones del tracto urinario causadas por enterobacterias: aproximación a su conocimiento y pautas de actuación]]></article-title>
<source><![CDATA[Actas Urol Esp]]></source>
<year>2014</year>
<volume>38</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>678-84</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hadifar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moghoofei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nematollahi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ramazanzadeh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sedighi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salehi-Abargouei]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Miri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of multidrug resistant uropathogenic Escherichia coli in Iran: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Jpn J Infect Dis]]></source>
<year>2017</year>
<volume>70</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-25</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ansari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nepal]]></surname>
<given-names><![CDATA[HP]]></given-names>
</name>
<name>
<surname><![CDATA[Gautam]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Shrestha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Neopane]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gurung]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal]]></article-title>
<source><![CDATA[Antimicrob Resist Infect Control]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>15</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rijavec]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Starcic Erjavec]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ambrozic Avgustin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Reissbrodt]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fruth]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Krizan-Hergouth]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups]]></article-title>
<source><![CDATA[Curr Microbiol]]></source>
<year>2006</year>
<volume>53</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>158-62</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Linder]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Steinman]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzales]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Stafford]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fluoroquinolone prescribing in the United States: 1995 to 2002]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2005</year>
<volume>118</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>259-68</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fasugba]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Das]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mnatzaganian]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Collignon]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gardner]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of single-drug-, multidrug-, and extensively drug-antimicrobial resistance of Escherichia coli urinary tract infections: an Australian laboratory-based retrospective study]]></article-title>
<source><![CDATA[J Glob Antimicrob Resist]]></source>
<year>2019</year>
<volume>16</volume>
<page-range>254-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Colqui]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Cieza]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados a la presentación de infecciones urinarias por Escherichia coli productoras de betalactamasas de espectro extendido]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2017</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>142-9</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro-Orozco]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Barreto-Maya]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán-Álvarez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega-Quiroz]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Benítez-Peña]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patrones de resistencia antimicrobiana en uropatógenos gramnegativos aislados de pacientes ambulatorios y hospitalizados]]></article-title>
<source><![CDATA[Rev Salud Pública]]></source>
<year>2010</year>
<volume>12</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1010-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
